Health
For Children With This Rare Disease, a Drug Has Finally Been Shown to Help Them Live Longer
The FDA has approved Lembaz, the first treatment shown to extend survival in infantile-onset Niemann-Pick disease type C. Patients on the drug had a 55 percent lower risk of death — in a disease that affects roughly one in 150,000 people.
